Health House for sale as parent company remains suspended from ASX by Steve Jones September 12, 2024September 12, 2024 Melodiol Global Health remains suspended from the Australian Securities Exchange (ASX) as it emerged that its […]
Company news: Avecho; Bioxyne; Elixinol Wellness; IDT Australia; Melodiol Global Health; Zelira by Steve Jones July 31, 2024November 25, 2024
Melodiol inks deal to sell Mernova facility to wipe out debts by Steve Jones July 23, 2024November 25, 2024
Melodiol ponders options amid ‘challenging and volatile capital markets’ by Steve Jones June 19, 2024June 19, 2024
Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024
Company news: Bioxyne/BLS; Rua Bioscience; Botanix; Melodiol Global Health; Zelira; Argent BioPharma by Martin Lane and Steve Jones April 16, 2024July 16, 2024
Health House to open its own telehealth clinic this quarter by Martin Lane April 9, 2024July 16, 2024
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024November 25, 2024
